유럽의 래터럴 플로우 분석 시장 : 지역별 분석 - 제품 유형, 수법, 검사 유형, 용도, 최종 사용자별 예측(-2030년)

The Europe lateral flow assay market was valued at US$ 2,558.72 million in 2022 and is expected to reach US$ 4,820.39 million by 2030; it is estimated to register a CAGR of 8.2% from 2022 to 2030.

Rising Popularity of Point-of-Care Testing Drives Europe Lateral Flow Assay Market

Lateral flow assay-based point-of-care (POC) diagnostic tools are rapid, easy-to-use, and low-cost paper-based procedures, which are specifically perceived to be beneficial in resource-limited settings and industrialized countries. These tests are increasingly replacing prolonged, conventional laboratory methods. No training and complex infrastructures are required to run POC diagnostic tests. Thus, these tests cost less than conventional laboratory diagnostic techniques. POC testing tools are expected to be a crucial revenue pocket in the lateral flow assay market because of their prominent role in combating the burgeoning disease burden. Many companies are engaged in developing innovative lateral flow assay-based POC devices for infectious disease diagnosis, drugs-of-abuse screening, pregnancy (using hCG levels) and ovulation confirmation, and blood protein marker measurement.

The rising popularity of POC testing and ongoing developments in lateral flow assay-based POC testing fuel the growth of the lateral flow assay market.

Europe Lateral Flow Assay Market Overview

Germany, the UK, France, Italy, and Spain are the major countries in Europe, including the rest of European countries. Germany held the largest market for lateral flow assay in the region in 2022. The growth of the lateral flow assay market in the region is attributed to factors such as the increasing geriatric population, the growing rate of accidents, and population growth in the region. Other major drivers include technological innovations and increasing demand for technologies in Germany, France, and the UK.

The pharmaceutical industry in Germany holds the global fourth largest position with small and mid-sized companies. According to the International Trade Administration (ITA), the pharmaceutical market in Germany accounted for US$ 62.5 billion in 2019 and will expect to increase in future. The country is likely to remain one of the most attractive destinations for the global pharmaceutical industry in the coming years in terms of manufacturing and supply. According to the ECDC's Annual epidemiological report, chlamydia infection, campylobacteriosis, salmonellosis, gonorrhea, and tuberculosis were the most frequently reported notifiable infectious diseases in the EU and The European Economic Area (EEA).

Europe Lateral Flow Assay Market Revenue and Forecast to 2030 (US$ Million)

Europe Lateral Flow Assay Market Segmentation

The Europe lateral flow assay market is categorized into product type, technique, test type, application, end user, and country.

Based on product type, the Europe lateral flow assay market is bifurcated into kits & reagents and lateral flow readers. The kits & reagents segment held a larger Europe lateral flow assay market share in 2022.

In terms of technique, the Europe lateral flow assay market is segmented into sandwich assay, competitive assays, and multiplex detection assay. The sandwich assay segment held the largest Europe lateral flow assay market share in 2022.

By test type, the Europe lateral flow assay market is divided into lateral flow immunoassay and nucleic acid lateral flow assay. The lateral flow immunoassay segment held a larger Europe lateral flow assay market share in 2022.

Based on application, the Europe lateral flow assay market is categorized into clinical testing, veterinary diagnostics, food safety & environment testing, and drug development & quality testing. The clinical testing segment held the largest Europe lateral flow assay market share in 2022.

By end user, the Europe lateral flow assay market is segmented into hospitals and clinics, diagnostics laboratories, homecare, veterinary clinics, pharmaceutical & biotechnology companies, and others. The hospitals and clinics segment held the largest Europe lateral flow assay market share in 2022.

By country, the Europe lateral flow assay market is segmented into the UK, Germany, France, Spain, Italy, Benelux, and the Rest of Europe. Germany dominated the Europe lateral flow assay market share in 2022.

F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Becton Dickinson and Co, PerkinElmer Inc, Hologic Inc, QIAGEN NV, bioMerieux SA, QuidelOrtho Corp, Abbott Laboratories, Merck KGaA, Bio-Rad Laboratories Inc, and Thermo Fisher Scientific Inc are some of the leading companies operating in the Europe lateral flow assay market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe Lateral Flow Assay Market - Key Industry Dynamics

• 4.1 Europe Lateral Flow Assay Market - Key Industry Dynamics
• 4.2 Market Drivers
  • 4.2.1 Increasing Use of Home-Based Assay Kits
  • 4.2.2 Rising Popularity of Point-of-Care Testing
• 4.3 Market Restraints
  • 4.3.1 Inconsistent Assay Results Due to Procedural Limitations
• 4.4 Market Opportunities
  • 4.4.1 Evolving Applications of Lateral Flow Assays
• 4.5 Future Trends
  • 4.5.1 Smartphone Usage and AI Integration in Lateral Flow Immunoassay
• 4.6 Impact analysis

5. Lateral Flow Assay Market - Europe Market Analysis

• 5.1 Europe Lateral Flow Assay Market Revenue (US$ Mn), 2020 - 2030

6. Europe Lateral Flow Assay Market Analysis - Product Type

• 6.1 Kits & Reagents
  • 6.1.1 Overview
  • 6.1.2 Kits & Reagents: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 6.2 Lateral Flow Readers
  • 6.2.1 Overview
  • 6.2.2 Lateral Flow Readers: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe Lateral Flow Assay Market Analysis - Technique

• 7.1 Sandwich Assay
  • 7.1.1 Overview
  • 7.1.2 Sandwich Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 7.2 Competitive Assays
  • 7.2.1 Overview
  • 7.2.2 Competitive Assays: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 7.3 Multiplex Detection Assay
  • 7.3.1 Overview
  • 7.3.2 Multiplex Detection Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe Lateral Flow Assay Market Analysis - Test Type

• 8.1 Lateral Flow Immunoassay
  • 8.1.1 Overview
  • 8.1.2 Lateral Flow Immunoassay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 8.2 Nucleic Acid Lateral Flow Assay
  • 8.2.1 Overview
  • 8.2.2 Nucleic Acid Lateral Flow Assay: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe Lateral Flow Assay Market Analysis - Application

• 9.1 Clinical Testing
  • 9.1.1 Overview
  • 9.1.2 Clinical Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.2 Veterinary Diagnostics
  • 9.2.1 Overview
  • 9.2.2 Veterinary Diagnostics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.3 Food Safety & Environment Testing
  • 9.3.1 Overview
  • 9.3.2 Food Safety & Environment Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 9.4 Drug Development & Quality Testing
  • 9.4.1 Overview
  • 9.4.2 Drug Development & Quality Testing: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe Lateral Flow Assay Market Analysis - End User

• 10.1 Hospitals and Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals and Clinics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.2 Diagnostics Laboratories
  • 10.2.1 Overview
  • 10.2.2 Diagnostics Laboratories: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.3 Homecare
  • 10.3.1 Overview
  • 10.3.2 Homecare: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.4 Veterinary Clinics
  • 10.4.1 Overview
  • 10.4.2 Veterinary Clinics: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.5 Pharmaceutical & Biotechnology Companies
  • 10.5.1 Overview
  • 10.5.2 Pharmaceutical & Biotechnology Companies: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)
• 10.6 Others
  • 10.6.1 Overview
  • 10.6.2 Others: Europe Lateral Flow Assay Market, Revenue and Forecast to 2030 (US$ Million)

11. Europe Lateral Flow Assay Market - Country Analysis

• 11.1 Europe Lateral Flow Assay Market, Revenue and Forecast to 2030
  • 11.1.1 Europe Lateral Flow Assay Market Revenue and Forecasts and Analysis - By Country
    • 11.1.1.1 Germany: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.1.1 Overview
      • 11.1.1.1.2 Germany Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.1.3 Germany Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.1.4 Germany Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.1.5 Germany Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.1.6 Germany Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.1.7 Germany Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.2 UK: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.2.1 Overview
      • 11.1.1.2.2 UK Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.2.3 UK Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.2.4 UK Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.2.5 UK Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.2.6 UK Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.2.7 UK Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.3 France: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.3.1 Overview
      • 11.1.1.3.2 France Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.3.3 France Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.3.4 France Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.3.5 France Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.3.6 France Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.3.7 France Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.4 Italy: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.4.1 Overview
      • 11.1.1.4.2 Italy Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.4.3 Italy Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.4.4 Italy Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.4.5 Italy Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.4.6 Italy Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.4.7 Italy Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.5 Spain: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.5.1 Overview
      • 11.1.1.5.2 Spain Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.5.3 Spain Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.5.4 Spain Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.5.5 Spain Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.5.6 Spain Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.5.7 Spain Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.6 Benelux: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.6.1 Overview
      • 11.1.1.6.2 Benelux Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.6.3 Benelux Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.6.4 Benelux Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.6.5 Benelux Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.6.6 Benelux Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.6.7 Benelux Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)
    • 11.1.1.7 Rest of Europe: Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.7.1 Overview
      • 11.1.1.7.2 Rest of Europe Lateral Flow Assay Market Revenue and Forecasts to 2030 (US$ Mn)
      • 11.1.1.7.3 Rest of Europe Lateral Flow Assay Market, by Product Type, 2020-2030 (US$ Million)
      • 11.1.1.7.4 Rest of Europe Lateral Flow Assay Market, by Technique, 2020-2030 (US$ Million)
      • 11.1.1.7.5 Rest of Europe Lateral Flow Assay Market, by Test Type, 2020-2030 (US$ Million)
      • 11.1.1.7.6 Rest of Europe Lateral Flow Assay Market, by Application, 2020-2030 (US$ Million)
      • 11.1.1.7.7 Rest of Europe Lateral Flow Assay Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

• 12.1 Overview
• 12.2 Growth Strategies in the Lateral Flow Assay Market
• 12.3 Organic Growth Strategies
  • 12.3.1 Overview
• 12.4 Inorganic Growth Strategies
  • 12.4.1 Overview

13. Company Profiles

• 13.1 F. Hoffmann-La Roche Ltd
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
• 13.2 Siemens Healthineers AG
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
• 13.3 Becton Dickinson and Co
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
• 13.4 PerkinElmer Inc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
• 13.5 Hologic Inc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
• 13.6 QIAGEN NV
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
• 13.7 bioMerieux SA
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
• 13.8 QuidelOrtho Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
• 13.9 Abbott Laboratories
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
• 13.10 Merck KGaA
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
• 13.11 Bio-Rad Laboratories Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments
• 13.12 Thermo Fisher Scientific Inc
  • 13.12.1 Key Facts
  • 13.12.2 Business Description
  • 13.12.3 Products and Services
  • 13.12.4 Financial Overview
  • 13.12.5 SWOT Analysis
  • 13.12.6 Key Developments

14. Appendix

• 14.1 About The Insight Partners
• 14.2 Glossary of Terms